The celebrated Portuguese soccer star, has recently taken a strategic step into the wellness industry by investing in Bioniq, a UK-based personalized health technology company. This significant investment has elevated Bioniq’s valuation to $82 million, underscoring the robust growth trajectory of the wellness sector and the expanding interest in personalized health solutions.
Ronaldo’s Multifaceted Role: From User to Investor
Ronaldo’s involvement is not just financial; as a longtime user of Bioniq’s products since 2022, he brings both personal endorsement and valuable insight into athlete-focused product development. His comments reflect a deep commitment to health and longevity, emphasizing Bioniq’s potential to revolutionize health maintenance and performance optimization. He stated, “Backing Bioniq goes beyond just an investment opportunity—it’s about aligning with a shared vision for health, performance, and longevity”.
This move comes at a time when the wellness market, especially personalized supplementation, is seeing explosive growth. The U.S. alone accounts for over 60% of Bioniq’s sales, highlighting the significant global demand for customized health solutions. Bioniq’s expansion strategy now aims to strengthen its footprint across the U.S., Europe, and the Middle East.
The company’s cutting-edge, Swiss-made supplements incorporate a blend of up to 120 nutrients, delivered in unique prebiotic granules designed to maximize absorption. Bioniq’s approach also boasts partnerships with elite sports and health institutions and has become a trusted brand among top athletes globally, including champions in soccer, the NBA, and endurance sports.
